Avidity Biosciences Inc. News, Avidity Biosciences Inc. Quote, RNA Quote

Avidity Biosciences Inc. (NQ:RNA) Delayed: 11.58 +0.09 (0.78%)

Prev. Close

$11.49

Today 6M 1Y 5Y

Open

$11.61

52 Wk High

$22.80

52 Wk Low

$4.12

Day High

$11.67

Day Low

$11.46

P/E

N/A

EPS

$0.00

Volume

22,780

Friends, Peers and Foes (?): RNAM, DYN, NVS, PTCT, BHVN (more...)

ALERTS | RSS

Jul 20, 2026 05:58 PM Atrium Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Jul 14, 2026 06:30 AM FDA clears Atrium Therapeutics IND for rare heart disease drug
Jul 14, 2026 06:30 AM Atrium Therapeutics Announces FDA Clearance of Investigational New Drug Application for ATR 1072 for Treatment of PRKAG2 Syndrome
Jun 23, 2026 04:05 PM Atrium Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Jun 18, 2026 06:07 AM Cantor Fitzgerald Starts Atrium Therapeutics (RNA) at Neutral
May 15, 2026 06:08 AM Leerink Partners Starts Atrium Therapeutics (RNA) at Outperform
May 14, 2026 04:40 PM Atrium Therapeutics Reports First Quarter 2026 Financial Results
Apr 23, 2026 08:01 AM Atrium Therapeutics receives $15 million milestone from Bristol Myers Squibb
Apr 23, 2026 08:00 AM Atrium Therapeutics Earns $15 Million Milestone Payment from Bristol Myers Squibb Under Global Cardiovascular Collaboration
Apr 20, 2026 10:46 PM Atrium Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Entities mentioned with RNA

View All Entities